Teijin Pharma
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 Shoreline Hwy Ste B386, Mill Valley,...Phone Number
(415) 893-1518Website
www.teijin-pharma.comRevenue
$36 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Teijin Pharma
Teijin Pharma is Teijin Pharma and Teijin Pharma's strength is the synergy between Teijin Pharma's 2 fields of business in pharmaceuticals and home healthcare. Through this synergy, Teijin Pharma is able to provide unique and revolutionary solutions on a global scale.Explore more
Teijin Pharma Org Chart
TI
President
MT
President
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teijin Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Teijin Pharma has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Teijin Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Teijin Pharma recently announced quarterly report
Check if Teijin Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Teijin Pharma launches new products
Check out if Teijin Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Teijin Pharma
Teijin Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Teijin Pharma
Compare insights from companies similar to Teijin Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Teijin Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Teijin Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Teijin Pharma.
Teijin Pharma Tech Stack
A closer look at the technologies used by Teijin Pharma
Teijin Pharma News & Media
Teijin Receives Additional Approval in Japan for Merz’s Xeomin® Botulinum Toxin Type A
FRANKFURT, Germany--(BUSINESS WIRE)--Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly announced today that Teijin Pharma has been granted additional approval by Japan’s Ministry of Health, Labor and Welfare (MHLW) to market Xeomin® (incobotulinumtoxinA) for intramuscular injection in 50, 100 or 200 units for the treatment of lower limb spasticity. Lower limb spTakeda vai vender quatro produtos de diabetes no Japão para a Teijin Pharma Limited
OSAKA, Japão--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) anunciou hoje que celebrou um acordo para transferir os ativos, direitos de marketing e, eventualmente, autorização de marketing associada a um portfólio de produtos não essenciais selecionados no Japão para a Teijin Pharma Limited ("Teijin Pharma"), uma empresa farmacêutica com sede em Tóquio, por 133 bilhões de ienes, sujeito às condições legais e regulamentares habituais de fechamento. O pTakeda va céder quatre produits pour le diabète au Japon à Teijin Pharma Limited
OSAKA, Japon--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO : 4502) (NYSE : TAK) (« Takeda ») a annoncé aujourd'hui avoir conclu un accord visant à transférer les actifs, les droits de commercialisation et, finalement, l'autorisation de commercialisation associée à un portefeuille de produits non stratégiques sélectionnés au Japon à Teijin Pharma Limited (« Teijin Pharma »), une société pharmaceutique basée à Tokyo, pour 133,0 milliards JPY, sous réserve des conditions de clôturTakeda venderá cuatro productos para diabetes en Japón a Teijin Pharma Limited
OSAKA, Japón--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) anunció hoy que ha firmado un acuerdo para transferir los activos, los derechos de comercialización y eventualmente la autorización de comercialización asociados con una cartera de productos exclusivos no esenciales en Japón a Teijin Pharma Limited (“Teijin Pharma”), una empresa farmacéutica con sede en Japón, por 133 000 millones de JPY, sujeto a las condiciones de cierre legales y reglament
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Teijin Pharma
Sign Up For FreeTo access detailed company insights
Teijin Pharma is Teijin Pharma and Teijin Pharma's strength is the synergy between Teijin Pharma's 2 fields of business in pharmaceuticals and home healthcare. Through this synergy, Teijin Pharma is able to provide unique and revolutionary solutions on a global scale.... Read More
